Literature DB >> 1616033

Macromolecular transport by rat gastric mucosa.

G H Curtis1, D G Gall.   

Abstract

We previously demonstrated that the stomach is capable of mounting a type I hypersensitivity reaction to luminal antigen challenge. These findings imply that antigenically intact macromolecules cross the gastric mucosa. To test this hypothesis, rat gastric mucosa was mounted in Ussing chambers, and bovine serum albumin (BSA, 0.5 mg/ml) and 125I-labeled BSA (10 microCi) were added to mucosal fluids. After equilibration, serosal fluids were sampled for two 30-min periods, and fluxes of immunologically intact BSA (determined by an enzyme-linked immunosorbent assay) and total BSA (125I-BSA) were calculated under basal conditions and in the presence of NaF and colchicine, and at 4 degrees C. Additional experiments examined macromolecular permeability in sensitized-challenged tissues. Immunologically intact BSA (21.3 +/- 4.5 ng.30 min-1.cm-2) crossed the gastric mucosa as approximately one-fourth of the total BSA flux (78.2 +/- 7.5 ng.30 min-1.cm-2). The uptake of immunologically intact BSA was significantly reduced by NaF, an inhibitor of ATP production and endocytosis; colchicine, which inhibits polymerization of cytoskeletal microtubules; and at 4 degrees C, a general metabolic inhibitor. The transmural passage of antigen was not significantly altered by immunoglobulin E-mediated anaphylaxis. These findings indicate that intact protein antigens cross the gastric mucosa by an active, energy-dependent mechanism that uses the microtubular network.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616033     DOI: 10.1152/ajpgi.1992.262.6.G1033

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Macromolecular transport across the rabbit proximal and distal colon.

Authors:  J A Hardin; M H Kimm; M Wirasinghe; D G Gall
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

2.  In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents.

Authors:  A F Goddard; R C Spiller
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

3.  Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model.

Authors:  T Matysiak-Budnik; K Terpend; S Alain; M J Sanson le Pors; J F Desjeux; F Mégraud; M Heyman
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.

Authors:  Tamara Matysiak-Budnik; Guillaume van Niel; Francis Mégraud; Kathryn Mayo; Claudia Bevilacqua; Valérie Gaboriau-Routhiau; Marie-Christiane Moreau; Martine Heyman
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

5.  Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination.

Authors:  A Mattsson; H Lönroth; M Quiding-Järbrink; A M Svennerholm
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

6.  Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators.

Authors:  A M Terrés; J M Pajares; A M Hopkins; A Murphy; A Moran; A W Baird; D Kelleher
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.